Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
The Co-Hosts of “Teenager Therapy” Return With New Podcast, “GrownKid”, to Help Guide their Generation Through the Realities of Young Adulthood
-
2024 International Quant Championship Global Finals To Kick Off in Singapore
-
The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement
-
Welltower to Participate in the BofA Securities 2024 Global Real Estate Conference
-
LuminUltra Acquires Legionella Testing Business from Genomadix and Inks Strategic License to Commercialize Additional Tests for Ultra-portable Molecular Diagnostic Platform
-
Tonix Pharmaceuticals Presented Data on the Potential Mpox Vaccine TNX-801 in “Using Synthetic Biology to Battle Mpox” Talk at Immunology Symposium at the University of Alberta
-
Achieve closes $263.3 million, AAA-rated personal loan securitization
-
HC Bioscience Appoints Simon Tsang, Ph.D. as Chief Business Officer to Lead Business Development
-
Identiv Completes Sale of its Physical Security Business
-
Alithya to co-present with McKesson at Oracle CloudWorld 2024
-
Mispro Announces Tenth Boston Location in Cambridge, MA
-
Rapid Finance Announces Integration With Q2’s Digital Banking Platform to Provide Small Business Lending Solutions
-
Swift Current Energy Secures $300 Million Facility to Support Renewable Energy Portfolio Buildout
-
Feed Ontario to release record-breaking food bank data on September 10, 2024
-
Blue Faery Continues Its Love Your Liver Campaign During Hispanic Heritage Month
-
SportsGrid Expands Content Offering with Brian Christopher Partnership
-
PERC Announces Pioneering Research Combining CO2, Wind and Solar to Produce Propane with Below-Zero Carbon Intensity
-
Target Announces Limited-Edition Collection for Pets and Pet Lovers
-
WellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men's Health
-
Nova Vision Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination to October 10, 2024
-
Roivant Provides Update on Graves’ Disease Development Program
-
Akero Therapeutics Announces First Patient Dosed in Phase 3 SYNCHRONY Outcomes Study of Efruxifermin in Patients with Compensated Cirrhosis Due to MASH
-
Canoo Expands Presence in Oklahoma and Texas with Engineering Talent and Headquarters Relocation
-
Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
-
Plug Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
-
Telesat Selects Calian to Develop and Deploy Element Management System for Telesat Lightspeed Network
-
Autonomix Announces 83% Reduction of Pain at 4-6 Week Follow-Up from Lead-In Patients in Ongoing Human Clinical Trial in Pancreatic Cancer Pain Patients
-
Superluminal Medicines Closes $120 Million Series A Round
-
Acrivon Therapeutics to Host Virtual Investor Event to Review Positive Phase 2 Clinical Data of ACR-368 Presented at ESMO and Pipeline Progress, Including Clinical Candidate ACR-2316
-
SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting
-
GXO CEO Malcolm Wilson to Join Fireside Chat at the Morgan Stanley 12th Annual Laguna Conference
-
Sol Systems Expands Midwest Presence with Acquisition of 2 GW of Clean Energy Projects
-
Euro Manganese Announces Offtake Term Sheet with FeMoCat Ltd
-
OTC Markets Group Welcomes Allied Gold Corp. to OTCQX
-
Mass General Brigham Releases Vision for Integrated, Patient-Centered Cancer Care
-
Solaris Submits Environmental Impact Assessment for Construction of Warintza; Announces Initial Steps to Emigrate to Ecuador
-
Major Drilling Announces Results of Annual Meeting of Shareholders
-
U.S. Special Operations Command Awards Contract to Quantexa
-
MoonLake Immunotherapeutics to host a Capital Markets Update on Wednesday, September 11
-
Evaxion obtains pre-clinical Proof-of-Concept for mRNA Gonorrhea vaccine candidate EVX-B2
-
Composition of the shareholders’ nomination board of Harvia Plc
-
Teekay Corporation Announces Update on $25 Million Share Repurchase Program and Announces New Share Repurchase Program
-
Zhong An Group(0672.HK) Seeks Sustainable Development
-
Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in Immuno-Oncology and Progression of Assets from Its Differentiated Research Platforms
-
Palantir and bp Agree to 5-Year Strategic Relationship With New AI Capabilities
-
Relay Therapeutics Announces Positive Interim Data for RLY-2608 Demonstrating Clinically Meaningful Progression Free Survival
-
Magnachip Expands Automotive Power Product Lineup with Four New 40V MXT MV MOSFETs
-
Sinch announces changes to its financial leverage policy
-
Beijing, Where Events Come Alive!
-
STG Global Finance B.V. – Announces results of the tender offer to purchase notes for cash
